Illumina IncILMN
Price$262.54Intrinsic value$141.8246% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $4.5B+2.8% YoYTTM through 28 Jun 2026
Net Income $825MTTM through 28 Jun 2026
Free Cash Flow $931MTTM through 28 Jun 2026

Margins

Current
Gross Margin66.1%
EBITDA Margin25.7%
Operating Margin19.2%
Net Margin18.4%

Returns

29.1%ROE
12.4%ROA

Balance Sheet Health

Current Ratio1.80x
Cash & Equivalents$1B

Quality Metrics

Altman Z-Score7.21
Piotroski F-Score8 / 9
FCF Margin20.7%
Rule of 4023.6
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'19'21'22'23'23'24'25
FY2025: $4.3B
Diluted EPS$5.36TTM
'19'21'22'23'23'24'25
FY2025: $5.45

Dividend

No dividend

Capital Allocation

R&D Spend$960M
Capex Intensity3.6%

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.